Nigeria’s Wegovy market is projected to grow at a CAGR of 18.2%, primarily driven by rising urban obesity and increased awareness of chronic diseases among middle- and upper-income groups. Access to obesity treatment remains largely restricted to private hospitals due to systemic healthcare challenges and affordability issues. A growing trend is the emergence of wellness clinics in Lagos and Abuja offering Western pharmacological solutions. Opportunities lie in targeting high-income demographics, expanding telemedicine platforms, and launching educational campaigns to shift perceptions about obesity as a treatable medical condition rather than a lifestyle choice.
TABLE - Nigeria Wegovy Market Size & Forecast By Route of Administration 2021-2033
Route of Administration | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injectable (Subcutaneous) | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Oral (Pipeline) | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis
TABLE - Nigeria Wegovy Market Size & Forecast By End-User 2021-2033
End-User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | CAGR (2024-2033) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospitals & Clinics | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Retail Pharmacies | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Online/Telehealth Platforms | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Total | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX | XXX |
Source: Company Publications, Primary Interviews, and SR Analysis